share_log

康健國際醫療:變更根據特別授權認購股份之所得款項用途

TOWN HEALTH: CHANGES IN USE OF PROCEEDS FROM SUBSCRIPTIONS OF SHARES UNDER SPECIFIC MANDATES

香港交易所 ·  Jan 12 07:55
Summary by Moomoo AI
康健國際醫療集團有限公司(「康健國際醫療」)於2024年1月12日宣布,鑒於全球經濟增速放緩及疫情對醫療健康行業的影響,董事會決定延長首筆及第二筆所得款項淨額未動用結餘的動用時間表至2026年底。該公司將取消原有的地域限制,以提供更大的靈活性,抓住全球醫療健康行業的機遇。此外,由於無法在原預算範圍內實現開發「一站式資訊科技網上平台」的目標,董事會決定不再向該項目投資,並將相關資金62百萬港元重新分配至其他醫療及健康相關業務。同時,996百萬港元的資金將用於收購、投資及發展醫療及健康相關業務,以更有效及靈活的方式部署資金。董事會相信,這些變更將更好地滿足公司的業務及營運需要,並符合公司及股東的整體利益。
康健國際醫療集團有限公司(「康健國際醫療」)於2024年1月12日宣布,鑒於全球經濟增速放緩及疫情對醫療健康行業的影響,董事會決定延長首筆及第二筆所得款項淨額未動用結餘的動用時間表至2026年底。該公司將取消原有的地域限制,以提供更大的靈活性,抓住全球醫療健康行業的機遇。此外,由於無法在原預算範圍內實現開發「一站式資訊科技網上平台」的目標,董事會決定不再向該項目投資,並將相關資金62百萬港元重新分配至其他醫療及健康相關業務。同時,996百萬港元的資金將用於收購、投資及發展醫療及健康相關業務,以更有效及靈活的方式部署資金。董事會相信,這些變更將更好地滿足公司的業務及營運需要,並符合公司及股東的整體利益。
HEALTH INTERNATIONAL MEDICAL GROUP LIMITED (“HEALTH INTERNATIONAL HEALTHCARE”) ANNOUNCED ON 12 JANUARY 2024 THAT IN VIEW OF THE SLOWING GLOBAL ECONOMIC SLOWDOWN AND THE IMPACT OF THE PANDEMIC ON THE HEALTHCARE INDUSTRY, THE BOARD OF DIRECTORS DECIDED TO EXTEND THE OPERATING TIMETABLE FOR FIRST AND SECOND NET PROCEEDS TO THE END OF 2026. The company will lift its original territorial restrictions to provide greater flexibility to seize opportunities in the global healthcare industry. In addition, due to the inability to achieve the objective of developing a “one-stop information technology web platform” within the original budget, the Board decided to no longer invest in the project and to reallocate HK$62 million of the relevant funds to other healthcare and health related businesses. At...Show More
HEALTH INTERNATIONAL MEDICAL GROUP LIMITED (“HEALTH INTERNATIONAL HEALTHCARE”) ANNOUNCED ON 12 JANUARY 2024 THAT IN VIEW OF THE SLOWING GLOBAL ECONOMIC SLOWDOWN AND THE IMPACT OF THE PANDEMIC ON THE HEALTHCARE INDUSTRY, THE BOARD OF DIRECTORS DECIDED TO EXTEND THE OPERATING TIMETABLE FOR FIRST AND SECOND NET PROCEEDS TO THE END OF 2026. The company will lift its original territorial restrictions to provide greater flexibility to seize opportunities in the global healthcare industry. In addition, due to the inability to achieve the objective of developing a “one-stop information technology web platform” within the original budget, the Board decided to no longer invest in the project and to reallocate HK$62 million of the relevant funds to other healthcare and health related businesses. At the same time, HK$996 million will be used to acquire, invest in and develop healthcare and health-related businesses to deploy funds in a more efficient and flexible manner. The Board believes that these changes will better meet the Company's business and operational needs and meet the overall interests of the Company and its shareholders.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more